Endologix

At Endologix, we are dedicated to pioneering innovative solutions that improve the lives of patients suffering from vascular diseases. Founded with a commitment to enhancing healthcare through disruptive advancements, we leverage an evidence-based approach to develop therapies specifically designed to address the pressing needs of patients and physicians alike. Our core mission revolves around empowering healthcare professionals through exceptional training and state-of-the-art technologies that redefine possibilities in treatment.

We focus on vascular innovations, specifically in the realm of endovascular therapies for abdominal aortic aneurysms (AAA) and peripheral artery diseases (PAD). As the industry progresses, we are proud to have established a diverse portfolio, including the ALTO® Abdominal Stent Graft System and the DETOUR® System, which offers unique treatment options previously unavailable. Through consistent engagement with clinical data, we ensure that our products not only meet but exceed the rigorous standards expected in the medical device field. Moreover, our commitment to ongoing education, including virtual reality procedural training, supports physicians in their efforts to provide optimal patient care.